Fig. 3
From: 68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer
SUVmax of the normal liver, PSMA-positive and PSMA-negative liver metastases in 2D ROI. The mean SUVmax of PSMA-positive liver metastases was 9.8 ± 4.9 and significantly higher than the mean SUVmax of the normal liver (4.8 ± 2.3, p ≤ 0.001). In contrast, the mean SUVmax of PSMA-negative liver metastases was 3.3 ± 1.8 and significantly lower than that of the normal liver (p ≤ 0.05). SUVmax Maximum standardized uptake value